Industry › BioTech
Press Releases
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in the United Arab Emirates
Aug 14, 2024 08:59 HKT/SGT
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
Aug 14, 2024 00:30 HKT/SGT
Eisai: Update Regarding the Regulatory Status of LEQEMBI Subcutaneous Formulation
Aug 06, 2024 12:15 HKT/SGT
Dual-action therapy shows promise against aggressive oral cancer
Jul 30, 2024 20:00 HKT/SGT
CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care
Jul 23, 2024 22:00 HKT/SGT
